P

Assignee

ALECTOR LLC

US48 patents

Top patents by PatentIndex Score

US10087255B2Oct 2, 2018

Anti-sortilin antibodies and methods of use thereof

ALECTOR LLC12 citations92
US10849992B1Dec 1, 2020

Methods of screening for sortilin binding antagonists

ALECTOR LLC6 citations84
US10676525B2Jun 9, 2020

Anti-TREM2 antibodies and methods of use thereof

ALECTOR LLC13 citations84
US11208488B2Dec 28, 2021

Methods of increasing progranulin levels using anti-Sortilin antibodies

ALECTOR LLC4 citations83
US11186645B2Nov 30, 2021

Isolated nucleic acids encoding anti-sortilin antibodies

ALECTOR LLC4 citations83
US10711062B2Jul 14, 2020

Anti-CD33 antibodies and methods of use thereof

ALECTOR LLC7 citations83
US10428150B2Oct 1, 2019

Anti-sortilin antibodies and methods of use thereof

ALECTOR LLC6 citations83
US10308718B2Jun 4, 2019

Anti-sortilin antibodies and methods of use thereof

ALECTOR LLC6 citations83
US11396546B2Jul 26, 2022

Anti-Sortilin antibodies and methods of use thereof

ALECTOR LLC2 citations72
US11339223B2May 24, 2022

Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injury

ALECTOR LLC2 citations72
US11319373B2May 3, 2022

Anti-SIRPA antibodies and methods of use thereof

ALECTOR LLC1 citations72
US11254743B2Feb 22, 2022

Anti-CD33 antibodies and methods of use thereof

ALECTOR LLC2 citations72
US10800844B2Oct 13, 2020

Anti-Siglec-9 antibodies and methods of use thereof

ALECTOR LLC2 citations72
US11634489B2Apr 25, 2023

Anti-TREM2 antibodies and methods of use thereof

ALECTOR LLC2 citations71
US11359014B2Jun 14, 2022

Anti-siglec-5 antibodies and methods of use thereof

ALECTOR LLC2 citations71
US11174313B2Nov 16, 2021

Anti-CD33 antibodies and methods of use thereof

ALECTOR LLC3 citations71
US11136390B2Oct 5, 2021

Anti-CD33 antibodies and methods of use thereof

ALECTOR LLC3 citations71
US11084875B2Aug 10, 2021

Anti-TREM2 antibodies and methods of use thereof

ALECTOR LLC4 citations71
US11472874B2Oct 18, 2022

Anti-MS4A4A antibodies and methods of use thereof

ALECTOR LLC3 citations70
US10590198B2Mar 17, 2020

Anti-siglec-7 antibodies and methods of use thereof

ALECTOR LLC2 citations70
US12247073B2Mar 11, 2025

Anti-CD33 antibodies and methods of use thereof

ALECTOR LLC1 citations63
US11667699B2Jun 6, 2023

Anti-MS4A4A antibodies and methods of use thereof

ALECTOR LLC3 citations63
US10875919B2Dec 29, 2020

Chimeric receptors and methods of use thereof

ALECTOR LLC1 citations63
US12258410B2Mar 25, 2025

Anti-SIRPα antibodies and methods of use thereof

ALECTOR LLC0 citations62
US12226482B2Feb 18, 2025

Anti-SIRP-alpha antibodies and methods of use thereof

ALECTOR LLC0 citations62
US12186409B2Jan 7, 2025

Methods of screening for sortilin binding antagonists

ALECTOR LLC0 citations62
US12004494B2Jun 11, 2024

Siglec transgenic mice and methods of use thereof

ALECTOR LLC0 citations62
US11976119B2May 7, 2024

Anti-SIRPa antibodies and methods of use thereof

ALECTOR LLC0 citations62
US11779642B2Oct 10, 2023

Anti-SIRP-alpha antibodies and methods of use thereof

ALECTOR LLC1 citations62
US11667710B2Jun 6, 2023

Anti-Siglec-9 antibodies and methods of use thereof

ALECTOR LLC0 citations62
US11147249B2Oct 19, 2021

Siglec transgenic mice and methods of use thereof

ALECTOR LLC1 citations62
US12358991B2Jul 15, 2025

Anti-Sortilin antibodies and methods of use thereof

ALECTOR LLC0 citations61
US12319734B2Jun 3, 2025

Anti-TMEM106B antibodies and methods of use thereof

ALECTOR LLC0 citations61
US12297277B2May 13, 2025

Anti-sortilin antibodies and methods of use thereof

ALECTOR LLC0 citations61
US12110327B2Oct 8, 2024

Anti-TREM1 antibodies and methods of use thereof

ALECTOR LLC0 citations61
US11965023B2Apr 23, 2024

Anti-Siglec-5 antibodies and methods of use thereof

ALECTOR LLC1 citations61
US11470827B2Oct 18, 2022

Transgenic mice expressing human TREM proteins and methods of use thereof

ALECTOR LLC0 citations61
US11472877B2Oct 18, 2022

Anti-TREM1 antibodies and methods of use thereof

ALECTOR LLC0 citations61
US11440957B2Sep 13, 2022

Anti-TMEM106B antibodies and methods of use thereof

ALECTOR LLC1 citations61
US11390680B2Jul 19, 2022

Anti-Siglec-7 antibodies and methods of use thereof

ALECTOR LLC1 citations60
US12331111B2Jun 17, 2025

Anti-MS4A4A antibodies and methods of use thereof

ALECTOR LLC0 citations59
US12331112B2Jun 17, 2025

Anti-MS4A4A antibodies and methods of use thereof

ALECTOR LLC0 citations59
US12258398B2Mar 25, 2025

Anti-Siglec-5 antibodies and methods of use thereof

ALECTOR LLC1 citations59
US11987612B2May 21, 2024

Siglec-9 ECD fusion molecules

ALECTOR LLC0 citations56
US12227568B2Feb 18, 2025

Anti-Siglec-7 antibodies and methods of use thereof

ALECTOR LLC0 citations51
US12060422B2Aug 13, 2024

Anti-SIRP-Beta1 antibodies and methods of use thereof

ALECTOR LLC0 citations51
US11897968B2Feb 13, 2024

Anti-MerTK antibodies and methods of use thereof

ALECTOR LLC0 citations51
US12215149B2Feb 4, 2025

Anti-MS4A6A antibodies and methods of use thereof

ALECTOR LLC0 citations50